Extended-cut Podcast—James Del Rosso, DO, and David G. Cotter, MD, PhD: Targeting the IL-31 Neuroimmune Pathway for Treating Prurigo Nodularis

Update: 2025-11-13

Description

Drs. Del Rosso and Cotter discuss advances in the molecular understanding of prurigo nodularis, which have enabled the development of targeted pharmaceuticals that treat the root of this condition.

Comments

In Channel

James Del Rosso, DO: JCAD November 2025 Issue Highlights

2025-11-2020:01

Extended-cut Podcast—James Del Rosso, DO, and David G. Cotter, MD, PhD: Targeting the IL-31 Neuroimmune Pathway for Treating Prurigo Nodularis

2025-11-1321:52

James Del Rosso, DO: JCAD October 2025 Issue Highlights

2025-10-3018:53

David G. Cotter, MD, PhD: The Ideal Patient Candidate for Deuruxolitinib for Patients with Alopecia Areata

2025-10-1601:45

David G. Cotter, MD, PhD: Utilizing the 31-gene Expression Profile Test in Patients with Melanoma

2025-10-0908:53

James Del Rosso, DO: JCAD September 2025 Issue Highlights

2025-09-2420:38

David G. Cotter, MD, PhD: Providing Regrowth of Hair in Patients with Alopecia Areata

2025-09-2206:33

James Del Rosso, DO: JCAD August 2025 Issue Highlights

2025-08-2619:21

JCAD Dialogues and Reviews: Updates in Photoprotection and Recent Indication Expansions in Psoriasis and Rosacea

2025-06-2308:55

James Del Rosso, DO: JCAD June 2025 Issue Highlights

2025-06-2016:21

Extended-cut Podcast— Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis

2025-05-2724:09